Skip to main content

Table 1 Demographic data

From: Adding a low-concentration sciatic nerve block to total knee arthroplasty in patients susceptible to the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs): a randomized controlled trial

 

Control (n = 25)

SNB (n = 25)

P-value

Female (n, %)

18 (72%)

19 (76%)

0.747

Age (mean ± SD)

73.88 ± 7.76

73.72 ± 6.94

0.939

BMI (mean ± SD)

28.51 ± 5.43

26.28 ± 3.00

0.080

Underlying disease

 CKD (n, %)

17 (68%)

16 (64%)

0.765

 DM (n, %)

11 (44%)

13 (52%)

0.571

 HT (n, %)

21 (84%)

24 (96%)

0.349

 IHD (n, %)

7 (28%)

7 (28%)

1.000

 Stroke (n, %)

8 (32%)

6 (24%)

0.529

 eGFR (mean ± SD)

48.90 ± 21.91

52.94 ± 22.13

0.520

 Preoperative pain (median [IQR])

3 (2–5)

4 (3–4.5)

0.835

 Operative time (min) (mean ± SD)

90 ± 21

95 ± 31

0.462

 Tourniquet time (min) (mean ± SD)

85 ± 17

84 ± 24

0.850

  1. BMI body mass index, CKD chronic kidney disease, Control control group, Cr creatinine, DM diabetes mellitus, eGFR glomerular filtration rate, HT hypertension, IHD ischemic heart disease, SNB popliteal-sciatic nerve block group